We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

11 hedge funds and large institutions have $19.9M invested in Summit Therapeutics in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

354% more capital invested

Capital invested by funds: $4.39M → $19.9M (+$15.5M)

0.79% more ownership

Funds ownership: 1.71% → 2.5% (+0.79%)

15% less funds holding

Funds holding: 13 → 11 (-2)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PC
Polar Capital
United Kingdom
+$5.5M
2
LPU
Lansdowne Partners (UK)
United Kingdom
+$4.52M
3
HSBC Holdings
HSBC Holdings
United Kingdom
+$329K
4
IC
Inscription Capital
Texas
+$29.2K
5
Wells Fargo
Wells Fargo
California
+$3.44K

Top Sellers

1
Bank of New York Mellon
Bank of New York Mellon
New York
-$347K
2
JMPWA
JP Morgan Private Wealth Advisors
California
-$80K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$68.8K
4
Morgan Stanley
Morgan Stanley
New York
-$65.6K
5
Renaissance Technologies
Renaissance Technologies
New York
-$35.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPU
1
Lansdowne Partners (UK)
United Kingdom
$10M +$4.52M +2,632,034 +165%
PC
2
Polar Capital
United Kingdom
$8.29M +$5.5M +3,200,000 +1,067%
Morgan Stanley
3
Morgan Stanley
New York
$464K -$65.6K -38,159 -16%
HSBC Holdings
4
HSBC Holdings
United Kingdom
$458K +$329K +191,483 New
Renaissance Technologies
5
Renaissance Technologies
New York
$401K -$35.3K -20,535 -11%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$214K -$68.8K -40,039 -31%
IC
7
Inscription Capital
Texas
$40K +$29.2K +17,000 New
ASN
8
Advisory Services Network
Georgia
$17K – – –
Wells Fargo
9
Wells Fargo
California
$5K +$3.44K +2,000 New
PFBT
10
Parkside Financial Bank & Trust
Missouri
$1K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
– -$347K -216,897 Closed
JMPWA
12
JP Morgan Private Wealth Advisors
California
– -$80K -50,000 Closed
Deutsche Bank
13
Deutsche Bank
Germany
– -$3K -1,961 Closed
Group One Trading
14
Group One Trading
Illinois
– -$1K -700 Closed

SMMT Hedge Fund Activity: Q1 2020 in Review

11 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q1 2020, worth a combined $19.9M — up 354% from $4.39M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SMMT and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.

The largest buyer was Polar Capital, adding an estimated $5.5M. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $347K sold.

  • 11 institutional investors held Summit Therapeutics (SMMT) as of Q1 2020, down from 13 in Q4 2019.
  • Funds reported $19.9M of Summit Therapeutics stock for Q1 2020, up 354% quarter-over-quarter.
  • 3 funds opened new Summit Therapeutics positions in Q1 2020 and 4 closed out, a net change of -1 holder.
  • The largest Summit Therapeutics buyer in Q1 2020 was Polar Capital, an estimated $5.5M added.
  • The largest Summit Therapeutics seller in Q1 2020 was Bank of New York Mellon, an estimated $347K sold.

Based on aggregated 13F filings for Q1 2020.